V5 Ultimate
Ultimate
PricingResourcesCompany
English (original)العربيةDeutschΕλληνικάEspañolFrançaisItalianoעברית日本語한국어NederlandsPolskiPortuguêsSvenska
Talk to us Log in Start free trial
Food & Beverage
  • Bakery & Confectionery
  • Food Processing
  • Ingredients & Dry Mixes
  • Sausage & Meat Products
  • Produce Packing
  • Pet Food & Pet Supplements
  • Dairy & Chilled Foods
  • Beverages & Liquid Manufacturing
  • Infant Formula
Pharma & Life Sciences
  • Radiopharmaceuticals
  • Pharmaceutical
  • Medical Devices
  • Veterinary Pharmaceuticals
  • Blood & Tissue
  • Diagnostics & IVD Kits
  • Reference Materials & Standards
  • OTC Topical Creams & Gels
Supplements & Personal Care
  • Dietary Supplements
  • Cosmetics & Personal Care
  • Cannabis & Hemp Manufacturing
  • Fragrances & Perfumery
  • Soaps & Personal Hygiene
  • Botanical Extracts & Essential Oils
Chemicals & Materials
  • Plastics & Resins
  • Agricultural Chemicals
  • Specialty & Industrial Chemicals
  • Printing Inks, Pigments & Construction Chemicals
  • Lubricants & Metalworking Fluids
  • Coatings, Adhesives & Sealants
Other Manufacturing
  • Consumer Products
  • Electronics & Electrical Assembly
  • Textiles & Nonwoven
  • Contract Manufacturing & Co-Packing
  • Packaging & Food-Contact Materials
  • Regulated Warehousing & Distribution
Explore all industries
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Why V5? Product & Features
Why V5?Product & Features
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Explore all industries
    • Bakery & Confectionery
    • Food Processing
    • Ingredients & Dry Mixes
    • Sausage & Meat Products
    • Produce Packing
    • Pet Food & Pet Supplements
    • Dairy & Chilled Foods
    • Beverages & Liquid Manufacturing
    • Infant Formula
    • Radiopharmaceuticals
    • Pharmaceutical
    • Medical Devices
    • Veterinary Pharmaceuticals
    • Blood & Tissue
    • Diagnostics & IVD Kits
    • Reference Materials & Standards
    • OTC Topical Creams & Gels
    • Dietary Supplements
    • Cosmetics & Personal Care
    • Cannabis & Hemp Manufacturing
    • Fragrances & Perfumery
    • Soaps & Personal Hygiene
    • Botanical Extracts & Essential Oils
    • Plastics & Resins
    • Agricultural Chemicals
    • Specialty & Industrial Chemicals
    • Printing Inks, Pigments & Construction Chemicals
    • Lubricants & Metalworking Fluids
    • Coatings, Adhesives & Sealants
    • Consumer Products
    • Electronics & Electrical Assembly
    • Textiles & Nonwoven
    • Contract Manufacturing & Co-Packing
    • Packaging & Food-Contact Materials
    • Regulated Warehousing & Distribution
PricingResourcesCompany
Start free trial Log in Talk to us
HomeGlossaryGluten-Free Labeling
Compliance · The complete guide

Gluten-Free Labeling: FDA 20 ppm Rule and Label Controls

In short

Understand the US FDA food-labeling framework and connect each claim decision to ingredients, verification evidence, controlled artwork and human approval.

4,236 words · ~20 min read
Quality technician in hair cover, mask, glasses and gloves checking a gluten-free bread label against its specification on a tablet
Gluten-free labeling claims must match what the label rule allows.
On this page
  1. 01Gluten-Free Labeling: FDA 20 ppm Rule and Label Controls
  2. 02US product scope and the fermented-food records branch
  3. 03Ingredient eligibility before a gluten result
  4. 04Below 20 ppm: interpreting results without shortcuts
  5. 05When wheat wording accompanies a gluten-free claim
  6. 06Oat-based products: connect sourcing to claim evidence
  7. 07From proposed claim to approved label use
  8. 08Evidence records, integrations and exception recovery
  9. 09Worked decisions: ingredients, the boundary and process records
  10. 10Failure modes and controls that preserve the decision trail
  11. 11Review checklist for a defensible claim decision
On this page · 11 sections
  1. 1Gluten-Free Labeling: FDA 20 ppm Rule and Label Controls
  2. 2US product scope and the fermented-food records branch
  3. 3Ingredient eligibility before a gluten result
  4. 4Below 20 ppm: interpreting results without shortcuts
  5. 5When wheat wording accompanies a gluten-free claim
  6. 6Oat-based products: connect sourcing to claim evidence
  7. 7From proposed claim to approved label use
  8. 8Evidence records, integrations and exception recovery
  9. 9Worked decisions: ingredients, the boundary and process records
  10. 10Failure modes and controls that preserve the decision trail
  11. 11Review checklist for a defensible claim decision
AI · Explain it for MY operation

How does Gluten-Free Labeling apply to your shop floor?

Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.

Your scale

01Gluten-Free Labeling: FDA 20 ppm Rule and Label Controls

What gluten-free labeling means under the FDA rule

Gluten-free labeling is the voluntary use of a gluten-free claim on US FDA-regulated food labels in accordance with 21 CFR 101.91. FDA’s explanatory material describes the claim as voluntary; the regulation establishes the binding conditions for its use.

For US FDA-regulated foods, a food bearing a gluten-free claim that fails the definition or applicable records provisions is deemed misbranded under 21 CFR 101.91(b)(1). For those foods, 21 CFR 101.91(b)(2) also covers the alternative claims “no gluten,” “free of gluten,” and “without gluten.”

In manufacturing practice, the following distinctions help teams keep the claim decision separate from the controls and evidence supporting it. The neighbouring terms are ordinary operational usage, not additional legal definitions.

TermMain questionEvidence roleBoundary
Gluten-free labelingCan this product bear the claim?Connects product evidence to label approval.The claim decision, not a handling procedure.
Wheat-free wordingWhat does the wording say about wheat?Focuses review on wheat-related ingredient information.Not a substitute for gluten-free claim review.
Gluten segregationHow are materials kept apart?Documents handling controls against cross-contact.A physical control, not label authorization.
Gluten testingWhat does analysis show about the sample?Provides analytical evidence for review.A result, not the complete claim decision.

For material-handling controls, see gluten-free segregation. This article instead concerns the decision to make and maintain a label claim. A practical review connects the approved label to the relevant formulation, process and supporting records; a batch release checklist can provide a handoff point for confirming that the intended label matches the reviewed product.

02US product scope and the fermented-food records branch

Start with product classification, destination market and processing history. For other markets or product categories, conduct a separate scope review rather than carrying over the FDA food threshold.

Jurisdiction and product or processRelevant provisionDecision addressedScope boundary
US FDA-regulated foods bearing the claim21 CFR 101.91Applicable gluten-free labeling frameworkVoluntary claim; conditions apply when used
US fermented or hydrolyzed foods bearing the claim101.91(c)(2), (4)Pre-process assurance and recordsConditional branch described below
US foods containing fermented or hydrolyzed ingredients101.91(c)(3), (4)Ingredient assurance and recordsConditional ingredient branch described below
US dietary-supplement ingredient declarations101.4(g)Listing non-dietary ingredientsDeclaration rule, not independent claim qualification

As established above, the claim is voluntary but conditional once used; this section addresses the records obligations that follow that conditional use. For US FDA-regulated foods, 21 CFR 101.91(a)(2) defines "gluten" as the proteins that naturally occur in a gluten-containing grain and that may cause adverse health effects in persons with celiac disease, such as prolamins and glutelins. That definition anchors every downstream ingredient and testing decision in this section. For US FDA-regulated foods, 21 CFR 101.91(c)(1) states that, when compliance is based on analysis of the food, FDA will use a scientifically valid method able to reliably detect and quantify 20 ppm gluten across a variety of food matrices, including raw and cooked or baked products. Manufacturers verifying their own results should select methods validated for the relevant matrix and processing state, not assume a single method suits every product form; the fermented-or-hydrolyzed records branch below exists precisely because that scientifically valid method is not always available.

When the specialised records branch applies

For US FDA-regulated fermented or hydrolyzed foods bearing the claim, 21 CFR 101.91(c)(2) requires manufacturers to make and keep assurance records when a scientifically valid method under paragraph (c)(1) is unavailable because the food is fermented or hydrolyzed. This is not a universal records obligation for every food.

For US FDA-regulated foods within that branch, the records must demonstrate adequate assurance of gluten-free status before fermentation or hydrolysis and adequate evaluation of processing for potential gluten cross-contact under 101.91(c)(2)(i)–(ii). For those US foods, where potential cross-contact is identified, the records must also demonstrate assurance that measures to prevent gluten introduction during manufacturing have been implemented under 101.91(c)(2)(iii).

For US FDA-regulated foods bearing the claim and containing fermented or hydrolyzed ingredients, 101.91(c)(3) requires corresponding ingredient-assurance records when a scientifically valid method under (c)(1) is unavailable because of those ingredients.

For US FDA-regulated foods subject to these records provisions, 101.91(c)(4) requires retention for at least 2 years after introduction or delivery for introduction into interstate commerce. For these US foods, records may be originals, true copies or electronic records; manufacturers must provide them to FDA for examination and copying during an inspection upon request.

For US dietary supplements, 21 CFR 101.4(g) requires non-dietary ingredients, such as excipients, in the ingredient list. Treat that declaration review separately from claim qualification.

As a practical record-design step, connect cross-contact controls to their supporting evidence and preserve the review history through an audit trail.

03Ingredient eligibility before a gluten result

For US FDA-regulated foods bearing a gluten-free claim, 21 CFR 101.91(a)(3)(i)(A) excludes the ingredient categories below. These are restrictions within the definition—not separate routes by which an ingredient qualifies.

  • Gluten-containing grain: for US FDA-regulated foods bearing the claim, 21 CFR 101.91(a)(3)(i)(A)(1) excludes an ingredient that is itself a gluten-containing grain, such as spelt wheat.
  • Grain-derived ingredient without gluten-removal processing: for US FDA-regulated foods bearing the claim, 21 CFR 101.91(a)(3)(i)(A)(2) excludes ingredients derived from a gluten-containing grain that have not been processed to remove gluten, such as wheat flour.
  • Grain-derived ingredient with gluten-removal processing: for US FDA-regulated foods bearing the claim, 21 CFR 101.91(a)(3)(i)(A)(3) excludes such an ingredient, exemplified by wheat starch, if its use results in 20 ppm or more gluten in the food. Processing to remove gluten therefore does not establish eligibility by itself; the condition concerns gluten in the finished food.

For US FDA-regulated foods, the alternative inherently-gluten-free branch in 21 CFR 101.91(a)(3)(i)(B) also connects to the additional criterion addressed in the following section; it is not a standalone exemption.

Practical ingredient review

A useful review sequence is to establish the purchased ingredient’s identity, identify its source material, examine relevant processing evidence, and connect the assessment to the current formula revision. This is an assessment practice, not a prescribed document format.

Keep evidence roles distinct: a supplier declaration states the supplier’s position; a specification defines agreed material characteristics; a processing description explains treatment of the source material. Review their contents rather than treating document titles as interchangeable proof. Record unresolved source or processing questions against the specific material. Link the reviewed material identity to ingredient-add verification so the formula assessment can follow through to manufacturing use.

04Below 20 ppm: interpreting results without shortcuts

For US FDA-regulated foods bearing a gluten-free claim, 21 CFR 101.91(a)(3)(ii) states that any unavoidable gluten presence is below 20 ppm: below 20 mg gluten per kg of food. For those foods, a result exactly at 20 ppm is not below the stated boundary. This is a mass-concentration expression, not an amount per serving.

Ask what the evidence actually describes

In manufacturing verification practice, these evidence types answer different questions; they are not interchangeable measurements:

  • A food result describes the sampled food, subject to the sampling design and analytical method.
  • An ingredient result describes an input, not necessarily the food after processing and handling.
  • A surface result addresses the sampled contact location, not gluten concentration in the food.
  • A supplier statement documents an assertion whose scope, material identity and supporting basis need review.

Read the report before making the decision

Practical laboratory-report review commonly checks sample identity, food matrix, method reference, result units, reporting limit, laboratory qualifiers and the decision being supported. Link the sample to the relevant material or food lot and confirm that the method context fits the matrix. A result reported below a reporting limit does not demonstrate absence; it describes what the report can establish at that limit. Consider whether the reporting limit permits the intended comparison at all.

As manufacturer practice, document sampling design, repeat-testing rules and internal action criteria for the product and process. Explain how samples represent the material under review, including relevant locations or processing stages. Keep internal criteria distinct from the label boundary, as discussed in label claims versus release limits. These are verification decisions, not additional statutory thresholds.

For an ambiguous report, a practical response is to pause the claim decision, obtain laboratory clarification and document whether further sampling or analysis is justified. Use a defined out-of-specification handling process where applicable; repeat testing should not silently replace the original evidence. For fermented-food questions that analytical evidence cannot resolve, return to the specialised records branch above rather than stretching the report’s meaning.

05When wheat wording accompanies a gluten-free claim

For US FDA-regulated foods, 21 CFR 101.91(b)(3) addresses labeling that bears “wheat” in the ingredient list or a separate “Contains wheat” statement, as required by 21 U.S.C. 343(w)(1)(A), and also bears “gluten-free” or an equivalent claim identified in paragraph (b)(2). Such labeling is deemed misbranded unless it meets the provision’s linked-symbol and explanatory-statement condition.

In this US FDA-regulated dual-label situation, the word “wheat” in the ingredient list or “Contains wheat” statement must be followed immediately by an asterisk or other symbol. That symbol must refer to a corresponding symbol close to the ingredient statement, immediately preceding this exact wording:

“The wheat has been processed to allow this food to meet the Food and Drug Administration (FDA) requirements for gluten-free foods.”

Artwork review in practice

A practical review compares the approved formula with the rendered label, rather than checking the explanatory sentence in isolation. Reviewers can:

  • Reconcile ingredient wording and the gluten-free claim text against the formulation decision.
  • Inspect the symbol immediately after wheat and its matching symbol beside the explanatory statement.
  • Check statement placement on the final artwork, not only in a text specification.

For supplement artwork, coordinate this comparison with the allergen-statement review. Keep the artwork approval linked to, but distinct from, the gluten-free eligibility decision discussed above; wheat wording and a correctly placed explanation are not substitutes for that decision.

06Oat-based products: connect sourcing to claim evidence

Consider a manufacturer purchasing rolled oats for an oat-based snack. As an operational risk review, assess the purchased material and its handling history rather than treating the ingredient name as proof of claim eligibility. Useful review points include:

  • Supplier identity and the material specification revision associated with the delivery.
  • Transport arrangements and receipt records relevant to potential cross-contact.
  • Storage and shared handling, including transfers into production.
  • Rework origin and whether its handling history is covered by the assessment.

Suppose purchasing substitutes another supplier’s rolled oats while the recipe remains unchanged. The ingredient description may stay the same, but the supporting evidence may differ. A practical supplier risk review connects the substitution to the supplier, incoming material lot and specification revision actually used in each affected finished-product lot. It identifies which previous conclusions remain applicable and which need reassessment, rather than carrying approval forward solely because the recipe is unchanged.

The handoff to the label reviewer typically contains the assessment outcome, linked supporting records and unresolved exceptions, with a named owner for follow-up. An exception-based review can direct attention to changed sourcing or incomplete handling evidence before the responsible person decides on label use. Detailed warehouse zoning, cleaning instructions and gluten-free segregation design belong in operational procedures; the label decision needs their relevant results, not a duplicate procedure. This keeps the review focused on whether the affected lot’s evidence supports the proposed claim.

07From proposed claim to approved label use

For a US food gluten-free claim, the following is a recommended manufacturer review design, not a prescribed FDA workflow. Assign responsibilities within the organisation’s quality assurance process; the functions below illustrate handoffs, not legally mandated job titles.

Workflow: product and market → formula screening → evidence branch → manufacturing exposure → artwork review → human approval → change reassessment. At each gate, record the reviewer, evidence considered and unresolved questions before advancing.

  1. Identify product and market. The claim owner defines the product, intended US market, manufacturing sites and proposed claim wording so reviewers assess a specific intended use.
  2. Screen the formula. Formulation reviews ingredients and subingredients. Purchasing obtains supplier specifications and processing information, linking them to the material versions used rather than relying on a supplier-wide assurance.
  3. Select the evidence branch. The technical reviewer identifies which analytical evidence and process records support the decision, including the specialised fermented or hydrolyzed branch covered above. Laboratory review assesses method suitability and result interpretation.
  4. Assess manufacturing exposure. Manufacturing documents relevant handling, shared equipment and rework conditions. A contract manufacturer contributes site-specific process evidence; the claim owner resolves gaps before approval.
  5. Review artwork. Label approval checks the proposed wording against the assessed formula and evidence, then identifies the exact artwork revision being considered.
  6. Document human approval. Designated people record the claim decision and its rationale, approve artwork issuance separately, and decide the disposition of affected stock through the applicable release process.
  7. Reassess changes. Route material substitutions, changed processing, new rework use, altered claim wording and revised artwork through change control.

For targeted reassessment, link each change to the affected material, formula, site, claim decision and artwork revision. Use those relationships to identify impacted products and stock; document why unrelated approvals remain outside scope.

Keep claim acceptability, permission to issue artwork and stock disposition as distinct decisions, even if one person holds multiple authorities. A laboratory result or software status supplies evidence, not approval authority. An electronic release record can be the designated record location, while approval and release remain human decisions.

Gluten-Free Claim Review
  1. 1
    Define scopeIdentify product, market and proposed wording.
  2. 2
    Screen IngredientsReview identity, source and processing evidence.
  3. 3
    Select evidenceMatch verification to food and process.
  4. 4
    Assess handlingReview contact routes, rework and changes.
  5. 5
    Review artworkCompare wording with approved product information.
  6. 6
    Approve useRecord the responsible person's decision.
  7. 7
    Reassess changesResolve exceptions before renewed approval.
A practical sequence with human approval and explicit change review.

08Evidence records, integrations and exception recovery

Use a proposed, system-neutral record structure to connect each gluten-free claim decision to the evidence reviewed. This voluntary schema is separate from the specialised legal records obligations covered above; it is not a prescribed regulatory database schema.

Suggested relationship map: claim decision → formula revision → ingredient evidence; claim decision → lot verification; claim decision → artwork revision. Give each record a stable identifier. Record the reviewer, disposition, rationale and evidence versions used, so later document replacements do not silently rewrite the decision history. This applies data integrity by design to the claim record.

  • Formulation or ERP interface: exchange product, formula-revision, ingredient and lot identifiers, with quantity units and the applicable formula version.
  • Supplier-document interface: map supplier material codes to internal ingredient identifiers; retain document identifiers, revisions and any stated measurement units.
  • Laboratory interface: link sample and lot identifiers to report and method revisions; preserve the result, reported unit and qualifiers. Laboratory integration should preserve these relationships rather than transfer a bare result.
  • Artwork interface: exchange product, market, artwork identifier and revision references. Mark measurement units as not applicable where the exchanged record contains no measurements; link the specific artwork version reviewed.

For exception recovery, retain the received information unchanged. Route an unmatched ingredient identifier to the material-data owner, a missing report unit to the laboratory contact, and an obsolete artwork reference to label control. Identify affected claim decisions through their linked records; keep the discrepancy unresolved while obtaining corrected evidence. Link the correction to the original, then record the accountable reviewer's disposition, rationale and any reassessment of affected decisions.

Treat software as support for evidence routing and decision documentation. A status flag, successful transfer or calculated threshold comparison is not certification, automatic quality release or a substitute for human approval.

Linked Claim Evidence

Claim Decision

Connects scope and human approval.

  • claim_id
  • market
  • formula_revision_id
  • artwork_revision_id
  • decision_status
  • approver_id

Formula Revision

Identifies the evaluated recipe.

  • formula_revision_id
  • ingredient_ids

Ingredient Evidence

Preserves source and process context.

  • ingredient_id
  • supplier_id
  • evidence_type
  • document_ref

Lot Verification

Connects results with method context.

  • verification_id
  • claim_id
  • lot_id
  • result_ppm
  • method_ref
  • reporting_limit_ppm

Artwork Revision

Identifies the claim-bearing label.

  • artwork_revision_id
  • claim_id
  • claim_text
  • wheat_statement_check
A suggested structure, not a prescribed regulatory schema.

09Worked decisions: ingredients, the boundary and process records

These hypothetical decision exercises are not measured production results. Each separates the regulatory conclusion from a proposed manufacturer action; the actions are practical controls, not additional legal requirements.

Wheat flour with a low result

Assumptions: A US FDA-regulated food intentionally contains wheat flour that has not been processed to remove gluten. Its finished-food report shows gluten below the stated threshold.

Regulatory conclusion: For this US FDA-regulated food, the ingredient restriction in 21 CFR 101.91(a)(3)(i)(A)(2) prevents qualification for the gluten-free claim. The low result does not override the wheat-flour restriction.

Proposed action: Reject the proposed claim for this formulation and return it to formulation and labeling reviewers rather than requesting another test to justify approval.

Processed wheat starch at the boundary

Assumptions: A US FDA-regulated finished food contains wheat starch processed to remove gluten. Its result is exactly 20 mg gluten per kg of food.

Regulatory conclusion: 20 mg/kg = 20 ppm. For this US FDA-regulated food, equality is not below the criterion in 21 CFR 101.91(a)(3)(ii). The stated result does not meet that criterion.

Proposed action: Withhold claim approval and route the result through out-of-specification handling, without inventing an uncertainty allowance or dilution calculation.

Changed hydrolyzed ingredient

Assumptions: A US FDA-regulated food contains a hydrolyzed ingredient, and the method-unavailability condition described above applies. The supplier changes; the review file contains only an end-product report.

Regulatory conclusion: For this US FDA-regulated food bearing the claim, 21 CFR 101.91(c)(3) requires records demonstrating adequate assurance that the hydrolyzed ingredient is gluten-free. An end-product report alone does not establish that ingredient assurance.

Proposed action: Mark claim approval pending review while quality assesses the relevant assurance records. Preserve the supplier change, record assessment and human approval decision in the audit trail.

10Failure modes and controls that preserve the decision trail

These are plausible information-control failures, not reported incidents or frequency estimates. The proposed controls target the handoff that can disconnect gluten-free claim evidence from the material, formula or label being reviewed.

FailureDetection signalPreventive controlRecovery owner
Evidence attached to the wrong materialReport material or lot identifier differs from the receiving record.Match supplier, material and lot identifiers before accepting the evidence link.Receiving quality reviewer
Unreviewed source substitutionPurchase source differs from the source covered by the claim assessment.Route supplier or manufacturing-site changes to quality review before use.Supplier quality lead
Report units lost during transferImported result has no unit or conflicts with the original report.Preserve original report units; check field mappings before accepting transferred results.Laboratory data reviewer
Artwork referencing an obsolete formulaArtwork approval points to a superseded formula revision.Check artwork-to-formula revision relationships at label issuance.Label approval owner
Unresolved exception treated as approvalApproval status appears despite an open discrepancy.Require an explicit reviewer disposition before advancing the claim decision.Quality decision owner

In a hybrid record system, apply these checks across paper-to-digital handoffs too. Correcting a link or restoring a unit repairs the record; it does not itself resolve the affected claim decision. Follow the exception-recovery sequence above, using exception-based review to distinguish correction from the human disposition of affected claim decisions.

11Review checklist for a defensible claim decision

Use these practical questions to review the completeness of a gluten-free claim decision before approving label use. They connect claims substantiation to the artwork and accountable human approval; they are not a separate regulatory checklist.

  • Is the intended market and product classification recorded?
  • Is the current formula linked by revision, rather than identified only by product name?
  • Are ingredient eligibility and process questions resolved, with the reasoning retained?
  • Does the supporting evidence match the product and lot under review?
  • Does the artwork match the approved claim decision and intended label version?
  • Is the human approver identified, with the decision and its scope recorded?
  • Are changes and exceptions assigned to named owners through change control or the appropriate exception workflow?
  • Can the record owner apply the relevant retention trigger, as covered above, and retrieve the correct revision?

Test the retrieval path

Select a claim-bearing artwork revision and trace it backward to the formula, ingredient evidence, applicable process records, verification information and approval decision. Use the batch record to check lot context where relevant. This is a suggested review technique, not a regulator-mandated exercise. Record broken links, ambiguous revisions and unexplained substitutions; assign an owner to resolve each gap and repeat the trace after correction.

Frequently asked questions

Q.Can wheat-free wording replace a gluten-free claim review?+

No. As a claim-review practice, assess the wording actually proposed rather than treating wheat-free wording as a substitute for gluten-free substantiation. For US FDA-regulated foods, 21 CFR 101.91(a)(3)(i)(A)(2) excludes ingredients derived from gluten-containing grains that have not been processed to remove gluten. A practical claims substantiation review examines ingredient identity, processing and manufacturing exposure. Keep that labeling decision distinct from gluten-free segregation, which addresses operational separation rather than approval of label wording.

Q.Can a supplier certificate alone justify changing a raw-material source?+

A practical review should not treat a certificate as the complete change assessment. Check whether it identifies the actual material, manufacturing site, applicable specification and supporting test or process evidence. Compare the proposed source with the approved source for ingredient composition, processing and cross-contact exposure. Use supplier risk management to identify missing evidence, then document the disposition through change control. Resolve material differences before authorizing use under the existing gluten-free claim decision.

Q.How should a reviewer handle a result below the laboratory's reporting limit?+

As explained in the reporting-limit discussion above, treat a below-reporting-limit result as a bounded finding, not proof of zero gluten, and confirm the reporting limit and method fit the matrix before relying on it. A distinct wrinkle is matrix suitability: for US FDA-regulated foods, 21 CFR 101.91(c)(1) expects a method able to reliably detect and quantify 20 ppm gluten across raw and cooked or baked forms, so a method validated on a raw ingredient does not automatically carry over to a baked finished food with a different matrix. Where the product moves through such a processing change, confirm the method's validated matrix before treating an ingredient-stage result as representative of the finished food, and route unresolved matrix questions through the label claim and release decision.

Q.What should be reassessed when a fermented or hydrolyzed ingredient changes?+

Reassess the ingredient's starting material, supplier process, gluten-control evidence and suitability of analytical evidence. For US FDA-regulated foods bearing a gluten-free claim, 21 CFR 101.91(c)(3) requires records providing adequate assurance that fermented or hydrolyzed ingredients are gluten-free when their presence makes a scientifically valid method under paragraph (c)(1) unavailable. As change-review practice, compare the old and new evidence and connect relevant fermentation batch records to the ingredient specification and affected formulas.

Q.What happens to claim approval when rework is added after formulation review?+

As a control practice, route the affected batch back for claim assessment rather than carrying forward approval of the unreworked formula. Identify the rework's source batches, composition, processing history and quantity, then assess whether the existing evidence still covers the resulting food. Capture the addition through ingredient add verification and make the unresolved claim decision visible in the batch release checklist. An authorized human reviewer should document the disposition before the batch proceeds with claim-bearing labeling.

Q.How should remaining label stock be handled when the approved claim decision changes?+

A practical label-control response is to block further issue of affected stock while its disposition is assessed. Identify printed labels, packaging components, work in progress and packed goods associated with the superseded artwork. Record quantities, locations and the authorized disposition, such as controlled relabeling or destruction where appropriate. Use bulk-to-pack traceability to identify affected production rather than assuming the change concerns only unused labels. Keep the stock decision linked to the revised claim approval and its effective production scope.

Q.How can a brand owner and contract manufacturer divide evidence and approval responsibilities?+

As an operating practice, define the division in a written responsibility matrix. The manufacturer can maintain ingredient, process, sampling and batch evidence; the brand owner can control proposed wording, artwork and market-facing specifications. Assign who evaluates gaps, approves changes and communicates restrictions before production or packaging proceeds. The quality assurance process should identify named decision owners and escalation routes. This allocation organizes work; it should not be described as transferring statutory responsibilities or allowing either party to approve claims without relevant evidence.

Q.How can a manufacturer retrieve inspection records without losing the formula and artwork revision context?+

As a records practice, assemble a batch-indexed package linking ingredient lots, the formula revision actually used, laboratory reports, the claim decision and the artwork revision issued to packaging. Preserve those historical relationships rather than relying on links that display only current versions. Use production context tagging to organize retrieval and an audit trail to retain change history. Test retrieval with a completed batch and confirm that a reviewer can reconstruct the decision without substituting later specifications or artwork.

Primary sources

  • 21 CFR 101.91
  • FDA: Gluten-Free Labeling of Foods
  • 21 CFR 101.4
Software that covers Gluten-Free Labeling
V5 Ultimate (FDA Compliance)
V5 Ultimate is a single-platform FDA compliance system for US manufacturers regulated under 21 CFR — pharma (210/211), medical…
Talk to us about Gluten-Free Labeling

Want to see how Gluten-Free Labeling could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.

Start free
Back to glossary
Inside V5
  • → Score your compliance gap — then download the validation pack.
  • → Document control — one version in force, every change signed and explained.
  • → QMS — quality records next to the work they concern.
Related terms
  • → 21 CFR Part 11
  • → EU Annex 11
  • → 21 CFR 211
  • → 21 CFR 820
  • → GAMP 5
  • → CSV
  • → CSA
  • → IQ / OQ / PQ

Next Step

Try V5 with your own records, or ask a question first. Ask V5 opens with an editable question; nothing is sent until you choose to.

Start your free trial Browse All Features

Showing the site for the United States. Local spelling, dates and prices are applied automatically; change the language at the top of the page.

V5 Ultimate
Ultimate

Warehouse, quality and manufacturing software for regulated operations.

ProductIndustriesPricingResourcesSecurity & TrustCompanyLegal Centre

© S.G. Systems, LLC